Patients with advanced clear cell RCC whose disease progressed after 1-3 prior systemic therapies (including an anti–PD- [L]1 therapy) were randomly assigned 1:1 to belzutifan 200 mg or 120 mg daily: ...

The trials in breast, lung, and colorectal cancer, supported by ARPA-H, will focus on guiding decisions across different lines of therapy using serial biopsies and tumor profiling.

Bionano Genomics, Inc. (Nasdaq: BNGO) today announced highlights from Day 3 of Bionano Symposium 2026, entitled OGM Making its Mark in Constitutional Genetic Disorders. Presentations highlighted how ...

Demonstrates Superior Sensitivity and Specificity of Caris DetectResults demonstrate the superiority of Whole Genome Sequencing compared to ...

During the 2026 Festival of Genomics & Biodata – an event at which scientists, clinicians, business leaders, tech companies, investors, patient organisations, and policymakers come together in seeking ...

NeoGenomics announced the launch of RaDaR® ST, its circulating tumor DNA assay for detecting molecular residual disease.

Element Biosciences Inc. today announced VITARI, the first ever high-throughput benchtop sequencing system capable of delivering a high-quality whole genome at $100.

Researchers are evaluating the P-CARE model, which integrates results from a blended genome-exome sequencing assay and family ...

BEVERLY, Mass., February 23, 2026--seqWell, a global leader in NGS library construction technology, today announced the ...

Well, a global leader in NGS library construction technology, today announced the launch of MosaiX, a next-generation library prep kit designed to streamline a wide range of high-throughput ...

Expecting Growth in 2026 Families are not just receiving results - they are gaining the confidence and capability to ...

Segun Fatumo discusses how he is working towards a true global genomics framework and strengthening African research capacity ...